283 results on '"Shimatsu, Akira"'
Search Results
2. Advanced proliferative diabetic retinopathy and macular edema in acromegaly: a case report and literature review
3. JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis
4. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase
5. Pleiotropic neuroprotective effects of taxifolin in cerebral amyloid angiopathy
6. A Prospective, Open-Label Short-Term Pilot Study on Modification of the Skin Hydration Status During Treatment With a Sodium-Glucose Cotransporter-2 Inhibitor
7. A Male Japanese Patient with Temple Syndrome Complicated by Type 2 Diabetes Mellitus
8. Sex differences in nicotine dependency and depressive tendency among smokers
9. Role of serum myostatin in the association between hyperinsulinemia and muscle atrophy in Japanese obese patients
10. Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial
11. THU032 Osilodrostat Is Effective And Well Tolerated In Patients Of Asian And Non-Asian Origin With Cushing's Disease: A Pooled Analysis From LINC 3 And LINC 4
12. Assessment of quality of life on 4-year growth hormone therapy in Japanese patients with adult growth hormone deficiency: A post-marketing, multicenter, observational study
13. Omega-3 polyunsaturated fatty acids suppress the inflammatory responses of lipopolysaccharide-stimulated mouse microglia by activating SIRT1 pathways
14. Lumbar Spinal Canal Stenosis in Acromegaly: A Case Report and Literature Review
15. Effect of statins on atherogenic serum amyloid A and α1-antitrypsin low-density lipoprotein complexes
16. Differential effects of GLP-1 receptor agonist on foam cell formation in monocytes between non-obese and obese subjects
17. Thrombospondin 1 as a novel biological marker of obesity and metabolic syndrome
18. Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: A multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS)
19. In the Phase III studies LINC 3 and LINC 4, osilodrostat was effective and well tolerated in patients of Asian and non-Asian origin with Cushing's disease
20. Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors
21. Smoking cessation reduces the lectin-like low-density lipoprotein receptor index, an independent cardiovascular risk marker of vascular inflammation
22. Prevalence and Pathogenesis of Macro-Thyrotropin in Neonates: Analysis of Umbilical Cord Blood from 939 Neonates and Their Mothers
23. The oral disposition index calculated from a meal tolerance test is a crucial indicator for evaluating differential normalization of postprandial glucose and triglyceride excursions in morbidly obese patients after laparoscopic sleeve gastrectomy
24. The effects of dietary instruction on cardiovascular risk markers after smoking cessation: study protocol for a multicenter randomized controlled trial in Japan
25. Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease
26. PMON163 Effect of Osilodrostat on Androgens and Adrenal Hormones in Patients With Cushing's Disease: Long-Term Findings From the Phase III, Prospective LINC 3 Study
27. Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extension
28. Abstract 16341: Biomarkers Predicting Cardiovascular Events Following Drug-Eluting Stent Implantation
29. Abstract 13751: Vascular Endothelial Growth Factor-C Levels and Cardiovascular and All-cause Mortality in Patients With Suspected Coronary Artery Disease: From the ANOX Study
30. Shortened saline infusion test for subtype prediction in primary aldosteronism
31. The effects of weight gain after smoking cessation on atherogenic α1-antitrypsin–low-density lipoprotein
32. Evaluation of the efficacy of osilodrostat in five patients with Cushing's syndrome: A single-center study
33. Change in androgens and adrenal hormones during long-term osilodrostat treatment in patients with Cushing's disease: Results from the Phase III, prospective LINC 3 study
34. Abstract #1183049: Hypertension (HTN) and Diabetes (DM) Improvement During Osilodrostat Therapy in Patients with Cushing’s Disease (CD): Analyses from the Phase III LINC 3 study
35. Abstract #1183056: Osilodrostat Therapy Improves Physical Features Associated with Hypercortisolism in Patients with Cushing’s Disease: Findings from the Phase III LINC 3 study
36. Clearance of macro-TSH from the circulation is slower than TSH
37. Telmisartan is the most effective ARB to increase adiponectin via PPARα in adipocyte
38. A possible cause of the variable detectability of macroprolactin by different immunoassay systems
39. Effects of a new 75 g glucose- and high fat-containing cookie meal test on postprandial glucose and triglyceride excursions in morbidly obese patients
40. Adult Growth Hormone Deficiency : A Practical Approach to Diagnosis and Treatment for Neurosurgeons
41. Macro TSH in patients with subclinical hypothyroidism
42. Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronism
43. Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis
44. Osilodrostat is an effective and well-tolerated treatment option for patients with Cushings disease (CD): Final results from the LINC3 study
45. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement
46. Abstract #1040637: Effect of Osilodrostat on Clinical signs, Physical Features and Health-related Quality of Life (HRQoL) by Degree of mUFC Control in Patients with Cushing’s Disease (CD): Results from the LINC3 Study
47. Durability of response and gender-based analysis from the LINC3 trial of osilodrostat in the treatment in cushing’s disease
48. Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia
49. Short-term Changes in Self-rating Depression Scale Scores after Smoking Cessation in Neurotic Patients
50. Successful management of a patient with active Cushing’s disease complicated with coronavirus disease 2019 (COVID-19) pneumonia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.